Navigation Links
WMIS Welcomes CMS Decision: Expanding Coverage for FDG-PET and Ending NOPR Data

Washington DC (PRWEB) June 18, 2013

On June 11, 2013 the Centers for Medicare & Medicaid Services (CMS) released a final decision memorandum concluding that FDG Position Emission Tomography (PET) is nationally covered to guide subsequent management of anti-tumor strategy, and the agency ended the requirement for prospective data collection. The National Oncological PET Registry (NOPR) was developed jointly by the ACR and WMIS as one of the first projects under the Coverage with Evidence Development (CED) program to determine if FDG-PET scans improve patient outcomes in the diagnosis and disease management for the Medicare population. Based upon the clinical and scientific data developed by NOPR and other researchers, in a landmark decision, CMS expanded coverage without data collection for FDG PET for all cancers for indications that CMS labels as “subsequent treatment strategy”, which includes uses more commonly described as treatment monitoring during therapy, restaging after completion of therapy, detection of suspected recurrence (restaging of patients with documented recurrence to plan additional therapy).

In a proposed decision memorandum, issued on March 13, 2013, CMS had limited coverage of subsequent treatment strategy FDG PET to one scan per patient per cancer, with any additional studies at the discretion of regional Medicare contractors. Based on data submitted by the NOPR and public comments from patient advocacy groups and physicians, CMS revised the final decision to cover three FDG-PET scans per patient. Coverage of any additional FDG-PET scans used to guide subsequent treatment strategy can be determined by regional Medicare contractors.

World Molecular Imaging Society played a leading role in the design and management of the National Oncological PET Registry. “WMIS has worked on a collaborative basis with CMS over the past ten years to develop clinical and scientific evidence and data to help patients and physicians. We are happy to have played a central role in one of the first CED projects, and are pleased that CMS recognized the work of NOPR. We hope that the long process of coverage for FDG-PET has laid a foundation for a more stream lined coverage of future oncology imaging agents. .” said Kim Pierce, the Executive Director of WMIS.

Commenting on the final decision, Barry Siegel of Washington University said, "Speaking on behalf of the entire NOPR Working Work, I am gratified at the culmination of our 7-year effort to obtain broader coverage for FDG-PET. The success of our foray into Coverage with Evidence Development speaks to a strong collaborative relationship with CMS, and we greatly appreciate CMS' responsiveness to the community's input in formulation of the final decision. My only regret is that our colleague Ed Coleman was not able to share this important event with us."

Professor Ed Coleman, a well-recognized PET advocate passed away in 2012.

In the final decision CMS also expanded the number of covered scans for subsequent treatment strategy to three scans and has indicated covering prostate. Dr. Steve Larson of Memorial Sloan-Kettering Cancer Center said "My colleagues and I are very pleased that FDG-PET is recognized by CMS for use in prostate cancer based on the peer reviewed literature and evidence. I think it says something good about the process that despite an initial proposed "non-coverage", upon re-review with additional data, CMS decided that PET FDG was reasonable and necessary for patients with progressing prostate cancer. CMS is to be commended for putting in place a review that was both thorough and fair."

Please note that this decision applies to the FDG-PET registry (NOPR-2009) only. The NaF-PET registry run jointly by ACR-WMIS will continue to collect additional data.

About WMIS:
The World Molecular Imaging Society (WMIS) is an academic and professional society for Molecular Imaging. From leading projects such as PET awareness campaigns and registry management on the clinical side to developing powerful preclinical models and training programs, WMIS is active across the entire spectrum of Molecular Imaging. WMIS is the world's most innovative and leading society in molecular imaging and molecular medicine. With the rise of the molecular imaging industry and the associated research, WMIS is the only organization that is connecting all the dots in the industry and is working to bring all stakeholders together by Smashing the Silos and Leading Innovation Convergence in molecular medicine through imaging; both for practitioners and researchers, who are defining the future of molecular imaging, WMIS enhances the potential and applications of innovation.

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Cepheid Welcomes Senior Vice President of Human Resources
2. The 14th Annual LOréal-Unesco Awards or Women on Science: From March 26 to March 29, Paris Welcomes and Honours Tomorrows Scientific Talents
3. Agendia Welcomes Dr. Mark Gittleman to Expanding Medical Advisory Board
4. United States Rocket Academy Welcomes XCOR Aerospace to Texas
5. Chiltern Welcomes Drs. Dieter Seitz-Tutter And Alexandra Adams
6. Elsevier Welcomes New Editor-in-Chief for European Urology
7. Ariosa Diagnostics Welcomes New Board Member Michael A. Aicher
8. ABC Welcomes New Advisory Board Members
9. CardioWise™ Welcomes Geoffrey Dalbow as Chief Technology Officer
10. Amphora Research Systems welcomes Advanced Polymer Monitoring Technologies
11. Jackson Hole Group, LLC Welcomes Marnie McBryde as a New Principal
Post Your Comments:
(Date:11/24/2015)... Worcester, Mass. (PRWEB) , ... November 24, 2015 ... ... need to maintain healthy metabolism. But unless it is bound to proteins, copper ... Institutes of Health (NIH), researchers at Worcester Polytechnic Institute (WPI) will conduct a ...
(Date:11/24/2015)... RALEIGH, N.C. , Nov. 24, 2015  Clintrax Global, Inc., ... Raleigh, North Carolina , today announced that the company has ... earnings represented a 391% quarter on quarter growth posted for Q3 ... Kingdom and Mexico , with the ... place in December 2015. --> United Kingdom ...
(Date:11/24/2015)... Muncie, IN (PRWEB) , ... November 24, 2015 , ... ... its newest Special Interest Group (SIG), MultiGP, also known as Multirotor Grand Prix, to ... in the last few years. Many AMA members have embraced this type of racing ...
(Date:11/24/2015)... 24, 2015  Tikcro Technologies Ltd. (OTCQB: TIKRF) today announced that its ... at 11:00 a.m. Israel time, at the law ... Allon Street, 36 th Floor, Tel Aviv, Israel ... and Izhak Tamir to the Board of Directors; ... directors; , approval of an amendment to certain terms of options ...
Breaking Biology Technology:
(Date:11/17/2015)... LIVERMORE, Calif. , Nov. 17, 2015  Vigilant ... has joined its Board of Directors. ... Vigilant,s Board after recently retiring from the partnership at ... owning 107 companies with over $140 Billion in revenue.  ... performance improvement across all the TPG companies, from 1997 ...
(Date:11/12/2015)... -- A golden retriever that stayed healthy despite having the ... a new lead for treating this muscle-wasting disorder, report ... MIT and Harvard and the University of São Paolo ... Cell, pinpoints a protective gene that boosts muscle ... Boston Children,s lab of Lou Kunkel , PhD, ...
(Date:11/11/2015)... MedNet Solutions , an innovative SaaS-based eClinical technology company that ... announce that it will be a Sponsor of the ... held November 17-19 in Hamburg , Germany.  ... iMedNet , MedNet,s easy-to-use, proven and affordable eClinical ... able to deliver time and cost savings of up to ...
Breaking Biology News(10 mins):